Phosphatases of regenerating liver are key regulators of metabolism in cancer cells – role of Serine/Glycine metabolism

por Abdollahi, Pegah, Vandsemb, Esten N., Børset, Magne
Publicado 2022

The serine protease matriptase inhibits migration and proliferation in multiple myeloma cells

por Steiro, Ida, Vandsemb, Esten N., Elsaadi, Samah, Misund, Kristine, Sponaas, Anne-Marit, Børset, Magne, Abdollahi, Pegah, Slørdahl, Tobias S.
Publicado 2022

Phosphatase of regenerating liver-3 is expressed in acute lymphoblastic leukemia and mediates leukemic cell adhesion, migration and drug resistance

por Hjort, Magnus A., Abdollahi, Pegah, Vandsemb, Esten N., Fenstad, Mona H., Lund, Bendik, Slørdahl, Tobias S., Børset, Magne, Rø, Torstein B.
Publicado 2017

Highly expressed genes in multiple myeloma cells – what can they tell us about the disease?

por Børset, Magne, Elsaadi, Samah, Vandsemb, Esten N., Hess, Eli Svorkdal, Steiro, Ida J., Cocera Fernandez, Miguel, Sponaas, Anne‐Marit, Abdollahi, Pegah
Publicado 2022

Phosphatase of regenerating liver 3 (PRL-3) is overexpressed in human prostate cancer tissue and promotes growth and migration

por Vandsemb, Esten N., Bertilsson, Helena, Abdollahi, Pegah, Størkersen, Øystein, Våtsveen, Thea Kristin, Rye, Morten Beck, Rø, Torstein Baade, Børset, Magne, Slørdahl, Tobias S.
Publicado 2016

The phosphatase of regenerating liver-3 (PRL-3) is important for IL-6-mediated survival of myeloma cells

por Slørdahl, Tobias S., Abdollahi, Pegah, Vandsemb, Esten N., Rampa, Christoph, Misund, Kristine, Baranowska, Katarzyna A., Westhrin, Marita, Waage, Anders, Rø, Torstein B., Børset, Magne
Publicado 2016

Phosphatase of regenerating liver-3 (PRL-3) is overexpressed in classical Hodgkin lymphoma and promotes survival and migration

por Hjort, Magnus Aassved, Hov, Håkon, Abdollahi, Pegah, Vandsemb, Esten Nymoen, Fagerli, Unn-Merete, Lund, Bendik, Slørdahl, Tobias Schmidt, Børset, Magne, Rø, Torstein Baade
Publicado 2018

Targeting phosphoglycerate dehydrogenase in multiple myeloma

por Elsaadi, Samah, Steiro, Ida, Abdollahi, Pegah, Vandsemb, Esten N., Yang, Rui, Slørdahl, Tobias S., Rø, Torstein Baade, Menu, Eline, Sponaas, Anne-Marit, Børset, Magne
Publicado 2021

Id-neoantigen vaccine induces therapeutic CD8(+) T cells against multiple myeloma: H chain-loss escapees cause FLC MM

por Westhrin, Marita, Blazevski, Jana, Textor, Ana, Abdollahi, Pegah, Gopalakrishnan, Ramakrishna Prabhu, Ngo, Linda Thuy, Hofgaard, Peter Olaf, Heinzelbecker, Julia, Bobic, Sonja, Fossum, Even, Spång, Heidi Cecilie Larsen, Braathen, Ranveig, Bogen, Bjarne
Publicado 2023

Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade

por Yang, Rui, Elsaadi, Samah, Misund, Kristine, Abdollahi, Pegah, Vandsemb, Esten Nymoen, Moen, Siv Helen, Kusnierczyk, Anna, Slupphaug, Geir, Standal, Therese, Waage, Anders, Slørdahl, Tobias S, Rø, Torstein Baade, Rustad, Even, Sundan, Anders, Hay, Carl, Cooper, Zachary, Schuller, Alwin G, Woessner, Richard, Borodovsky, Alexandra, Menu, Eline, Børset, Magne, Sponaas, Anne Marit
Publicado 2020